FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

36887511000001108: Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) 4 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Apr 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
113187401000001119 Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) 4 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
113187501000001115 Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) 4 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) 4 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) 4 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) 4 vial Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) 4 vial Has specific active ingredient Darvadstrocel true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) 4 vial Is a Darvadstrocel 30million cells/6ml suspension for injection vials 4 vial true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) 4 vial Has AMP Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) 4 vial Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) 4 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) 4 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) 4 vial Has specific active ingredient Darvadstrocel false Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) 4 vial Has dispensed dose form Conventional release suspension for injection true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) 4 vial Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) 4 vial Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) 4 vial Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start